SRRK241220C35000
- 5.50
- +1.61+41.39%
Scholar Rock Newsroom
Truist Financial Maintains Scholar Rock(SRRK.US) With Buy Rating, Maintains Target Price $45
H.C. Wainwright Maintains Scholar Rock(SRRK.US) With Buy Rating, Raises Target Price to $50
Promising Market Dynamics and Growth Potential for Scholar Rock's Apitegromab Boost Buy Rating
Scholar Rock Holding Is Maintained at Buy by HC Wainwright & Co.
Truist Financial Maintains Scholar Rock(SRRK.US) With Buy Rating, Announces Target Price $45
Jefferies Maintains Scholar Rock(SRRK.US) With Buy Rating, Maintains Target Price $50
Scholar Rock Holding Is Maintained at Buy by Truist Securities
Scholar Rock Holding Analyst Ratings
Scholar Rock Holding: Strategic Positioning and Pipeline Progress Justify Buy Rating Amid Reduced Competition
TD Cowen Maintains Scholar Rock(SRRK.US) With Buy Rating
Jefferies Maintains Scholar Rock(SRRK.US) With Buy Rating, Raises Target Price to $50
BMO Capital Maintains Scholar Rock(SRRK.US) With Buy Rating, Raises Target Price to $39
TD Cowen Maintains Scholar Rock(SRRK.US) With Buy Rating
H.C. Wainwright Maintains Scholar Rock(SRRK.US) With Buy Rating, Raises Target Price to $40
Scholar Rock Holding Analyst Ratings
Scholar Rock Holding's Promising Pipeline and Positive Trials Justify Buy Rating and Increased Price Target
Truist Financial Remains a Buy on Scholar Rock Holding (SRRK)
Truist Financial Maintains Scholar Rock(SRRK.US) With Buy Rating
Piper Sandler Maintains Scholar Rock(SRRK.US) With Buy Rating, Raises Target Price to $42
Scholar Rock Holding Is Maintained at Outperform by BMO Capital